Full Text
The Role of DSM in the EMA and FDA Authorization Process for Psychiatric Drugs

Abstract

Authors

O.I. Meyers

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×